Updated daily
Drug recalls
Every FDA drug recall since 2004 - 18,109 enforcement reports, newest first, with what was recalled, why, the lots and the company. Class I is the most serious.
Class IITerminatedSep 18, 2013TRIAMCINOLONE ACETONIDE 80 MG/ML INJ SUSPLack of Assurance of Sterility; FDA inspectional findings resulted in concerns associated with quality control procedures that impacted sterility assuranceBeacon Hill Medical Pharmacy, P.C. · D-1006-2013Class IITerminatedSep 18, 2013TRI-MIX 10 MCG/30 MG/1 MG/ML INJ SOLN and TRI-MIX 30 MCG/15 MG/2 MG/ML INJ SOLNLack of Assurance of Sterility; FDA inspectional findings resulted in concerns associated with quality control procedures that impacted sterility assuranceBeacon Hill Medical Pharmacy, P.C. · D-1005-2013Class IITerminatedSep 18, 2013TESTOSTERONE PROPIONATE 100 MG/ML OIL INJ SOLNLack of Assurance of Sterility; FDA inspectional findings resulted in concerns associated with quality control procedures that impacted sterility assuranceBeacon Hill Medical Pharmacy, P.C. · D-1004-2013Class IITerminatedSep 18, 2013TESTOSTERONE CYPIONATE 100 MG/MLLack of Assurance of Sterility; FDA inspectional findings resulted in concerns associated with quality control procedures that impacted sterility assuranceBeacon Hill Medical Pharmacy, P.C. · D-1003-2013Class IITerminatedSep 18, 2013TESTOSTERONE HYPOALLERGENIC 200 MG/ML INJECTABLE and TESTOSTERONE AQUEOUS 100 MG/ML INJECTABLELack of Assurance of Sterility; FDA inspectional findings resulted in concerns associated with quality control procedures that impacted sterility assuranceBeacon Hill Medical Pharmacy, P.C. · D-1002-2013Class IITerminatedSep 18, 2013SODIUM PHOSPHATE MONOBASIC/WATER FOR INJECTION 10%Lack of Assurance of Sterility; FDA inspectional findings resulted in concerns associated with quality control procedures that impacted sterility assuranceBeacon Hill Medical Pharmacy, P.C. · D-1001-2013Class IITerminatedSep 18, 2013SODIUM PHOSPHATE DIBASIC/WATER FOR INJECTION 10%Lack of Assurance of Sterility; FDA inspectional findings resulted in concerns associated with quality control procedures that impacted sterility assuranceBeacon Hill Medical Pharmacy, P.C. · D-1000-2013Class ITerminatedSep 11, 2013Velextra All-Natural Herbal SupplementMarketed Without an Approved NDA/ANDA; products have been found to contain tadalafil, the active ingredient in an FDA approved product used to treat erectile...Beamonstar Products · D-930-2013Class ITerminatedSep 11, 2013SexVoltz All Natural Herbal SupplementMarketed Without an Approved NDA/ANDA; products have been found to contain tadalafil, the active ingredient in an FDA approved product used to treat erectile...Beamonstar Products · D-929-2013Class IITerminatedSep 11, 2013CARBOplatin InjectionLack of Assurance of Sterility: The required reduction of endotoxin was not met during the annual revalidation of the vial washer.Teva Pharmaceuticals USA, Inc. · D-928-2013Class IITerminatedSep 4, 2013Diazepam InjectionLack of assurance of sterility: ineffective crimp on fliptop vials that may result in leaking at the neck of the vials.Hospira Inc. · D-927-2013Class IITerminatedSep 4, 2013Ketorolac Tromethamine InjLack of Assurance of Sterility: Either a loose crimp or no crimp was applied to the fliptop vials.Hospira, Inc. · D-926-2013Class IITerminatedSep 4, 2013Benztropine Mesylate InjectionPresence of particulate matter: characterized as thin colorless flakes that are visually and chemically consistent with glass delamination.Nexus Pharmaceuticals Inc · D-925-2013Class IITerminatedSep 4, 2013Propranolol Hydrochloride TabletsFailed Tablet/Capsule Specification: Teva is recalling certain lots of Propanolol HCl Tablets, 10 mg due to the potential of some tablets not conforming to weight...Teva Pharmaceuticals USA, Inc. · D-924-2013Class IITerminatedSep 4, 2013Lidocaine Hydrochloride 2% and Epinephrine 1:100Subpotent Drug; Two lots of Lidocaine 2% with Epinephrine 1:100,000 Injectable, distributed under the names: Octocaine 100, and 2% Xylocaine Dental, may be subpotent for...Novocol Pharmaceutical of Canada · D-923-2013Class ITerminatedSep 4, 20130.9% Sodium Chloride InjectionPresence of Particulate Matter; product may contain fibrous materialHospira Inc. · D-922-2013Class ITerminatedSep 4, 2013Bethel 30 capsulesMarketed Without An Approved NDA/ANDA: FDA analysis found this product contained undeclared sibutramine and phenolphthalein, two active ingredients that were once...Bethel Nutritional Consulting, Inc · D-921-2013Class ITerminatedSep 4, 2013Magnesium Sulfate InjectionPresence of Particulate Matter: Glass particulate matter was observed in a retention sample during an annual review.Fresenius Kabi USA, LLC · D-920-2013Class ITerminatedSep 4, 2013ENTERIC COATED ASPIRINLabeling: Label Mix-Up: A complaint from a pharmacist was received that the entire contents of 1 bottle labeled as Rugby label Enteric Coated Aspirin 81 mg Tablets...Advance Pharmaceutical Inc · D-919-2013Class IITerminatedSep 4, 2013AvastinLack of Assurance of Sterility; product linked to adverse event reports of endophthalimitis eye infections and FDA inspection findings resulted in concerns regarding...Clinical Specialties Compounding Pharmacy · D-918-2013Class IIITerminatedSep 4, 2013buPROPion Hydrochloride Extended-Release TabletsFailed Dissolution Specifications: This recall is an extension of the recall initiated on 07/31/2013 for Bupropion HCl Extended-Release Tablets (XL) 300 mg, because...Actavis South Atlantic LLC · D-917-2013Class IITerminatedAug 28, 2013CLENZIderm M.D. Acne Therapeutic System Normal to Oily Skin kitcGMP Deviations; during the production process, CLENZIderm M.D. Daily Foam Cleanser was filled into some bottles labeled as CLENZIderm M.D. Pore TherapyMedicis Pharmaceutical Corp · D-916-2013Class IITerminatedAug 28, 2013IRINOTECAN HYDROCHLORIDE INJECTIONCrystallization: Active pharmaceutical ingredient is precipitating in product solution.Fresenius Kabi USA LLC (FK USA) · D-915-2013Class IIITerminatedAug 28, 2013Tagitol V Barium Sulfate SuspensionFailed Stability Specifications: Tagitol V Barium Sulfate Lot #65846 sampled at 10 months exhibited results above the upper specification for viscosity.Bracco Diagnostics Inc · D-914-2013Class IITerminatedAug 28, 2013Nystatin Oral SuspensionFailed Impurites/Degradation Specifications: Test failure of single largest peak at 18 months.VistaPharm, Inc. · D-913-2013Class IITerminatedAug 28, 2013Eyebright Concentrate Topical Eye RinseLack of Assurance of Sterility; Lack of Assurance of Sterility; product not manufactured under sterile conditions as required for ophthalmic drug productsEarthlabs, Inc. DBA Wise Woman Herbals · D-912-2013Class IIITerminatedAug 28, 2013Braintree HalfLytely and Bisacodyl Tablet Bowel Prep KitDefective Container; Small micro fracture observed in the 2-Liter bottle at the fill line resulting in a small leak when patient reconstitutes the bulk powderBraintree Laboratories Inc. · D-911-2013Class IIITerminatedAug 28, 2013Maalox Nighttime Antacid with Acid Reflux BarrierLabeling: Incorrect or Missing Lot and/or Exp Date: The lot number and/or expiration date may be illegible on the outer plastic bottle packaging.Novartis Consumer Health · D-910-2013Class IIITerminatedAug 28, 2013Maalox Nighttime Antacid with Acid Reflux BarrierLabeling: Incorrect Or Missing Lot and/or Exp Date: The lot number and/or expiration date may be illegible on the outer plastic bottle packaging.Novartis Consumer Health · D-909-2013Class IIITerminatedAug 28, 2013Maalox Extra Strength Antacid with Anti-GasLabeling: Incorrect Or Missing Lot and/or Exp Date: The lot number and/or expiration date may be illegible on the outer plastic bottle packaging.Novartis Consumer Health · D-908-2013Class IIITerminatedAug 28, 2013Maalox, Regular Strength AntacidLabeling: Incorrect Or Missing Lot and/or Exp Date: The lot number and/or expiration date may be illegible on the outer plastic bottle packaging.Novartis Consumer Health · D-907-2013Class IIITerminatedAug 28, 2013Maalox Extra Strength AntacidLabeling: Incorrect Or Missing Lot and/or Exp Date: The lot number and/or expiration date may be illegible on the outer plastic bottle packaging.Novartis Consumer Health · D-906-2013Class IIITerminatedAug 28, 2013Maalox Advanced Maximum Strength Antacid & AntigasLabeling: Incorrect Or Missing Lot and/or Exp Date: The lot number and/or expiration date may be illegible on the outer plastic bottle packaging.Novartis Consumer Health · D-905-2013Class IIITerminatedAug 28, 2013Maalox Advanced Maximum Strength Antacid & AntigasLabeling: Incorrect Or Missing Lot and/or Exp Date: The lot number and/or expiration date may be illegible on the outer plastic bottle packaging.Novartis Consumer Health · D-904-2013Class IIITerminatedAug 28, 2013Maalox Regular Strength AntacidLabeling: Incorrect Or Missing Lot and/or Exp Date: The lot number and/or expiration date may be illegible on the outer plastic bottle packaging.Novartis Consumer Health · D-903-2013Class IIITerminatedAug 28, 2013Maalox Extra Strength Antacid with Anti-GasLabeling: Incorrect Or Missing Lot and/or Exp Date: The lot number and/or expiration date may be illegible on the outer plastic bottle packaging.Novartis Consumer Health · D-902-2013Class IIITerminatedAug 28, 2013Mavik¿ trandolapril tablets 4mgLabeling: Incorrect Package Insert; product packaged with outdated version of the insertAbbVie Inc. · D-901-2013Class IIITerminatedAug 28, 2013Nata KompleteSubpotent; Beta carotene (Vitamin A)Stayma Consulting Service, LLC. · D-900-2013Class IIITerminatedAug 28, 2013Duet DHA 430 ecSubpotent; Beta carotene (Vitamin A)Stayma Consulting Service, LLC. · D-899-2013Class IIITerminatedAug 28, 2013Duet DHA 430Subpotent; Beta carotene (Vitamin A)Stayma Consulting Service, LLC. · D-898-2013